Chemoradiotherapy followed by surgery could improve the efficacy of treatments in patients with resectable esophageal carcinoma

Chinese Medical Journal

Volumn 126, Issue 16, 2013, Pages 3138-3145

  Wang, Feng ^a   Wang, Ya mei ^a   He, Wei ^a   Li, Xiang ke ^a   Peng, Fang hui ^a   Yang, Xiao li ^a   Fan, Qing xia ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Chemoradiotherapy followed by surgery; Meta analysis; Oesophageal carcinoma; Randomized controlled trial; Surgery alone

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADENOCARCINOMA; CHEMORADIOTHERAPY; COMPARATIVE STUDY; ELECTRONIC MEDICAL RECORD; ESOPHAGUS CARCINOMA; HUMAN; META ANALYSIS; POSTOPERATIVE COMPLICATION; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SURGICAL MORTALITY; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CHEMORADIOTHERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVAL RATE;

EID: 84882236886     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20123438     Document Type: Review

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69 90.
2. Mao YS, He J, Cheng GY, Zhang RG. Current consensus and controversy of staging and treatment for esophageal cancer. Chin Oncol (Chin) 2011; 21: 511-517.
3. Kojima T, Hashimoto J, Kato K, Ito Y, Igaki H, Daiko H, et al. Feasibility study of neoadjuvant chemoradiotherapy with cisplatin plus 5-fluorouracil and elective nodal irradiation for stage II/III esophageal squamous cell carcinoma. J Clin Oncol 30, 2012; (suppl 4; abstr 130).
4. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of report of randomized clinical trials: is blinding necessary? Controlled Clin Trials 1996; 17: 1-12.
5. Mariette C, Seitz JF, Maillard E, Mornexet F, Thomas PA, Raoul J, et al. Surgery alone versus chemoradiotherapy followed by surgery for localized esophageal cancer: analysis of a randomized controlled phase III trial FFCD 9901. Proc Am Soc Clin Oncol 2010; 28 (15 suppl): 4005.
6. Gaast AV, van Hagen P, Hulshof M, Richel D, van Berge Henegouwen MI, Nieuwenhuijzen GA, et al. Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: results from a multicenter randomized phase III study. Proc Am Soc Clin Oncol 2010; 28 (15 suppl): 4004.
7. Nygaard K, Hagen S, Hansen HS, Hatlevoll R, Hultborn R, Jakobsen A, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992; 16: 1104-1109.
8. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology 1994; 41: 391 393.
9. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-1784.
10. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-467.
11. Bosset JF, Gignoux M, Triboulet JP, Tiret E, Mantion G, Elias D, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-167.
12. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-313.
13. An FS, Huang JQ, Xie YT, Chen SH, Rong TH. A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma. Chin J Oncol (Chin) 2003; 25: 376-379.
14. Lee JL, Park SI, Kim SB, Jung HY, Lee GH, Kim JH, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004; 15: 947-954.
15. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-668.
16. Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Yokomakura N, et al. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus 2006; 19: 468-472.
17. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fuorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008; 26: 1086-1092.
18. Peng L, Xie TP, Han YT, Lang JY, Li T, Fu BY, et al. Randomized controlled study on preoperative concurrent chemoradiotherapy versus surgery alone for esophageal squamous cell carcinoma. Tumor (Chin) 2008; 28: 620-622.
19. Jin MG, Jiang SC, Chen ZW, Wang ZQ. Clinical trial of preoperative concurrent chemoradiation followed by surgery versus surgery alone for advanced esophageal carcinoma. Chin J Cancer Prev Treat 2008; 15: 1815-1817.
20. Cao XF, He XT, Ji L, Xiao J, Lv J. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus 2009; 22: 477-481.
21. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Operation combined with preoperative radiochemotherapy on esophageal squamous carcinoma. Chin J Exp Surg (Chin) 2009; 26: 1378-1380.
22. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma. World J Gastroenterol 2010; 16: 1649-1654.
23. Xie J, Cui JC, Wang GC. The treatment value of neoadjuvant chemoradiotherapy in locally advanced esophageal cancer. J Nantong Univ (Med Sci) (Chin) 2010; 30: 488, 490.
24. Zhang WS, Pan KY, Cai ZS, Lin Y. A prospective study of preoperative concurrent chemoradiotherapy combined with surgery in the treatment of locally advanced esophageal carcinoma. Chin J Surg Oncol (Chin) 2011; 03: 266-268.
25. Jin FL, Hu ZL, Ma HF, Du JY. Treatment effect of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone in local advanced esophageal carcinoma. J Pract Oncol (Chin) 2011; 26: 523-526.
26. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012; 366: 2074-2084.
27. Yang H, Fu JH, Liu MZ, Fang WT, Wang JM, Chen YP, et al. A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus:an interim analysis. Natl Med J Chin (Chin) 2012; 92: 1028-1032.
28. Rutegard M, Charonis K, Lu Y, Lagergren P, Lagergren J, Rouvelas I. Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update. Surgery 2012; 152: 903-910.
29. Kelly P, Appleyard V, Murray K, Paulin F, Lamont D, Baker L, et al. Detection of oesophageal cancer biomarkers by plasma proteomic profiling of human cell line xenograf ts in response to chemotherapy. Br J Cancer 2010; 103: 232-238.
30. Kobayashi N, Nakayama H, Osaka Y, Tachibana S, Nogi S, Tajima Y, et al. Tumor response after low-dose preoperative radiotherapy combined with chemotherapy for squamous cell esophageal carcinoma. Anticancer Res 2013; 33: 1157-1161.
31. Siddiqui FA, Dolan JP, Hunter JG, Douthit MA, Bloker LM, Holland JM, et al. Retrospective analysis of neoadjuvant chemoradiotherapy for esophageal cancer: the Knight Cancer Institute experience. J Clin Oncol 30, 2012; (suppl 4; abstr 126).
32. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ, Barbour A, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12: 681-692.
33. Bagheri R, RajabiMashhadi MT, Ghazvini K, Asnaashari A, Zahediyan A, Sahebi MA. The effect of neoadjuvant chemoradiotherapy on airway colonization and postoperative respiratory complications in patients undergoing oesophagectomy for oesophageal cancer. Interact Cardiovasc Thorac Surg 2012; 14: 725-728.
34. Njei BM, Appiah J, Ditah IC, Birk JW. Chemoradiotherapy plus surgery versus surgery alone for resectable esophageal cancer: a systematic review of randomized control trials. J Clin Oncol 30, 2012; (suppl 4; abstr 94).
35. Zheng B, Zheng W, Zhu Y, Lin XY, Xu BH, Chen C. Role of adjuvant chemoradiotherapy in treatment of resectable esophageal carcinoma: a meta-analysis. Chin Med J 2013; 126: 1178-1182.
36. Vallböhmer D, Schröder W, Brabender J, Hölscher AH. Oesophageal cancer: current status of multimodality therapy. Zentralbl Chir 2011; 136: 312-316.
37. Zemanova M, Novak F, Vitek P, Pazdro A, Smejkal M, Pazdrova G, et al. Outcomes of patients with oesophageal cancer treated with preoperative chemoradiotherapy, followed by tumor resection: influence of nutritional factors. J BUON 2012; 17: 310-316.
38. Hingorani M, Crosby T, Maraveyas A, Dixit S, Bateman A, Roy R. Neoadjuvant chemoradiotherapy for resectable oesophageal and gastro-oesophageal junction cancer-do we need another randomised trial? Clin Oncol (R Coll Radiol) 2011; 23: 696-705.
39. Fan QX. Neoadjuvant therapy of esophageal cancer. The tumor multidisciplinary diagnosis and treatment of the concept Symposium Proceedings 2010: 54-58.